Akpolat, Tekin2021-10-252021-10-252021Akpolat T. (2021). Reduced CoronaVac vaccine antibody response in patients with chronic kidney disease. International urology and nephrology, 1–2. Advance online publication. https://doi.org/10.1007/s11255-021-03023-1https://doi.org/10.1007/s11255-021-03023-1https://hdl.handle.net/20.500.12713/2174Chronic kidney disease (CKD) is a risk factor for higher morbidity and mortality for coronavirus (COVID-19) infection caused by severe acute respiratory syndrome coronavirus 2. There are different vaccines against COVID-19 infection. CoronaVac is an inactivated virus vaccine and data regarding its efficacy is limited.eninfo:eu-repo/semantics/openAccessLetter34661822WOS:0007083616000032-s2.0-85117180459Q310.1007/s11255-021-03023-1N/A